Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Luca Richeldi

15PUBLICATIONS
54CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

Sort by Publication Date:
|May 05, 2026
Pamufetinib (TAS-115) for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A double-blind, multicenter, phase 2b Clinical Trial.

|Mar 10, 2026
Bexotegrast for treatment of idiopathic pulmonary fibrosis (BEACON-IPF): study protocol for a multinational, phase 2b/3, double-blind, randomised, multicentre, controlled trial.

Wim A Wuyts, Lisa Lancaster, Toby M Maher

|Mar 22, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease.

Oliver Distler, Madelon C Vonk, Arata Azuma

|Mar 05, 2025
The interstitial lung disease patient pathway: from referral to diagnosis.

Graham Lough, Rayid Abdulqawi, Gina Amanda

|Dec 23, 2024
Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan.

Yoshikazu Inoue, Takashi Ogura, Arata Azuma

|Sep 29, 2023
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.

Ganesh Raghu, Sydney B Montesi, Richard M Silver

Pageof 3

Frequent Collaborators

4 joint publications

Yoshikazu Inoue

3 joint publications

Vincent Cottin

3 joint publications

Martin Kolb

3 joint publications

Claudia Valenzuela

3 joint publications

Toby M Maher

2 joint publications

Yasuhiro Kondoh

1 joint publications

Yasunari Miyazaki

1 joint publications

Kozo Morimoto

1 joint publications

Yuji Minegishi

1 joint publications

Kiminobu Tanizawa

Frequent Collaborators

4 joint publications

Yoshikazu Inoue

3 joint publications

Vincent Cottin

3 joint publications

Martin Kolb

3 joint publications

Claudia Valenzuela

Top Related Videos

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on : Apr 13, 2018

11.0K
A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on : Jan 16, 2026

337
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on : Jun 16, 2020

19.7K
See more related videos

Top Related Videos

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on : Apr 13, 2018

11.0K
A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on : Jan 16, 2026

337
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on : Jun 16, 2020

19.7K
See more related videos